These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32051301)

  • 41. [Medication use in diabetes mellitus (VI). Economics and effectiveness of insulin and sulfonyl-urea combination therapy compared with conventional two daily doses].
    Costa B; Estopá A; Borrás J; Sabaté A
    Med Clin (Barc); 1998 Nov; 111(15):568-72. PubMed ID: 9859089
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sulphonyurea as a cause of severe hypoglycaemia in the community.
    Ng JM; Mellor DD; Masson EA; Allan BJ
    Prim Care Diabetes; 2010 Apr; 4(1):61-3. PubMed ID: 20064751
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Severe hypoglycaemia during treatment with sulphonylureas in patients with type 2 diabetes in the Capital Region of Denmark.
    Pilemann-Lyberg S; Thorsteinsson B; Snorgaard O; Zander M; Vestergaard H; Røder ME
    Diabetes Res Clin Pract; 2015 Nov; 110(2):202-7. PubMed ID: 26515912
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
    Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypoglycaemia Among Insulin-Treated Patients with Diabetes: Evaluation of the United Arab Emirates cohort of the International Operations-Hypoglycaemia Assessment Tool study.
    Abusnana S; Beshyah SA; Al-Mutawa N; Tahhan R; Jallo M; Arora R; Aly H; Singhal S
    Sultan Qaboos Univ Med J; 2018 Nov; 18(4):e447-e454. PubMed ID: 30988962
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Determinants for inadequate glycaemic control in Chinese patients with mild-to-moderate type 2 diabetes on oral antidiabetic drugs alone.
    Zhang SL; Chen ZC; Yan L; Chen LH; Cheng H; Ji LN
    Chin Med J (Engl); 2011 Aug; 124(16):2461-8. PubMed ID: 21933588
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Type 2 diabetes mellitus, glycaemic control, associated therapies and risk of rheumatoid arthritis: a retrospective cohort study.
    Zemedikun DT; Gokhale K; Chandan JS; Cooper J; Lord JM; Filer A; Falahee M; Nirantharakumar K; Raza K
    Rheumatology (Oxford); 2021 Dec; 60(12):5567-5575. PubMed ID: 33590842
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glycaemic control of Asian patients with type-2 diabetes mellitus on tiered up-titration of metformin monotherapy: A one-year real-world retrospective longitudinal study in primary care.
    Gao Q; Tan NC; Fang HSA; Lee ML; Hsu W
    Diabetes Res Clin Pract; 2022 May; 187():109874. PubMed ID: 35436547
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Determinants of glycaemic control in a practice setting: the role of weight loss and treatment adherence (The DELTA Study).
    McAdam-Marx C; Bellows BK; Unni S; Mukherjee J; Wygant G; Iloeje U; Liberman JN; Ye X; Bloom FJ; Brixner DI
    Int J Clin Pract; 2014 Nov; 68(11):1309-17. PubMed ID: 25113816
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extent and Predictors of Poor Glycaemic Control among Elderly Pakistani Patients with Type 2 Diabetes Mellitus: A Multi-Centre Cross-Sectional Study.
    Atif M; Saleem Q; Asghar S; Malik I; Ahmad N
    Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658518
    [No Abstract]   [Full Text] [Related]  

  • 51. Temporal patterns of hypoglycaemia and burden of sulfonylurea-related hypoglycaemia in UK hospitals: a retrospective multicentre audit of hospitalised patients with diabetes.
    Rajendran R; Kerry C; Rayman G;
    BMJ Open; 2014 Jul; 4(7):e005165. PubMed ID: 25009134
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of perceived stress, concern about hypoglycaemia and level of knowledge of management of the disease on glycaemic control in type 1 diabetes mellitus.
    Grau-Del Valle C; Marco-Expósito JF; Bosch-Sierra N; Zaragoza-Villena B; Solá E; Montoya-Castilla I; Morillas C; Bañuls C
    J Clin Nurs; 2023 Jan; 32(1-2):264-272. PubMed ID: 35224806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adherence to the American Diabetes Association's Glycemic Goals in the Treatment of Diabetes Among Older Americans, 2001-2018.
    Le P; Ayers G; Misra-Hebert AD; Herzig SJ; Herman WH; Shaker VA; Rothberg MB
    Diabetes Care; 2022 May; 45(5):1107-1115. PubMed ID: 35076695
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Potential diabetes overtreatment and risk of adverse events among older adults in Ontario: a population-based study.
    Lega IC; Campitelli MA; Austin PC; Na Y; Zahedi A; Leung F; Yu C; Bronskill SE; Rochon PA; Lipscombe LL
    Diabetologia; 2021 May; 64(5):1093-1102. PubMed ID: 33491105
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Present status of sulfonylurea treatment for type 2 diabetes in Japan: second report of a cross-sectional survey of 15,652 patients.
    Arai K; Matoba K; Hirao K; Matsuba I; Takai M; Takeda H; Kanamori A; Yamauchi M; Mori H; Terauchi Y
    Endocr J; 2010; 57(6):499-507. PubMed ID: 20208396
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comorbidity, hypoglycaemia and appropriate selection of antidiabetic pharmacotherapy in diabetic patients with heart failure in clinical practice in Germany. Results of the DiaRegis registry.
    Gitt AK; Bramlage P; Binz C; Krekler M; Deeg E; Tschöpe D
    Herz; 2012 May; 37(3):294-300. PubMed ID: 22476616
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Optimal utilisation of sulphonylureas in resource-constrained settings.
    Naidoo P; Rambiritch V; Butkow N; Saman S
    Cardiovasc J Afr; 2014; 25(2):83-5. PubMed ID: 24844554
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quality improvement project for improving inpatient glycaemic control in non-critically ill patients admitted on medical floor with type 2 diabetes mellitus.
    Khan AA; Shahzad A; Rose S; Al Mohanadi DHSH; Zahid M
    BMJ Open Qual; 2020 Aug; 9(3):. PubMed ID: 32792342
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sulfonylurea use and the risk of hospital readmission in patients with type 2 diabetes.
    Heaton PC; Desai VC; Kelton CM; Rajpathak SN
    BMC Endocr Disord; 2016 Jan; 16():4. PubMed ID: 26786291
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rate of glycaemic control and associated factors in patients with type 2 diabetes mellitus treated with insulin-based therapy at selected hospitals in Northwest Ethiopia: a multicentre cross-sectional study.
    Sendekie AK; Belachew EA; Dagnew EM; Netere AK
    BMJ Open; 2022 Sep; 12(9):e065250. PubMed ID: 36691186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.